Rosuvastatin in the Prevention of Stroke Among Men and Women With Elevated Levels of C-Reactive Protein - Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER)

Black tea reduces uric acid and C-reactive protein levels in humans susceptible to cardiovascular diseases.

Higher Level of Systemic C-Reactive Protein Is Independently Predictive of Coronary Heart Disease in Older Community-Dwelling Adults: The Three-City Study.

Insulin resistance is associated with C-reactive protein independent of abdominal obesity in nondiabetic Taiwanese.

Utility of Waist-To-Height Ratio in Detecting Central Obesity and Related Adverse Cardiovascular Risk Profile Among Normal Weight Younger Adults (from the Bogalusa Heart Study)

Dietary patterns and cardiovascular risk markers in the UK Low Income Diet and Nutrition Survey

Circulating inflammatory and haemostatic biomarkers are associated with risk of myocardial infarction and coronary death, but not angina pectoris, in older men.

The JUPITER Trial: How Will It Change Clinical Practice?

Levels of C-Reactive Protein Associated with High and Very High Cardiovascular Risk Are Prevalent in Patients with Rheumatoid Arthritis

Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot study

Age-related differences in inflammatory markers in men: contribution of visceral adiposity

High-sensitivity C-reactive protein at different stages of atherosclerosis: results of the INVADE study

Cardiovascular Disease Risk Prediction With and Without Knowledge of Genetic Variation at Chromosome 9p21.3

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

Differential Impact of Admission C-Reactive Protein Levels on 28-Day Mortality Risk in Patients With ST-Elevation Versus Non–ST-Elevation Myocardial Infarction (from the Monitoring Trends and Determinants on Cardiovascular Diseases [MONICA]/Cooperative Health Research in the Region of Augsburg [KORA

Use of combined oral contraceptives alters metabolic determinants and genetic regulation of C-reactive protein. The Cardiovascular Risk in Young Finns Study

C-Reactive protein predicts severity, progression, and prognosis of asymptomatic aortic valve stenosis

Association of Parental Obesity with Concentrations of Select Systemic Biomarkers in Non-obese Offspring: The Framingham Heart Study

Effects of Antidiabetic and Antihyperlipidemic Agents on C-Reactive Protein

Association of high sensitive C-reactive protein with apolipoprotein E polymorphism in children and young adults: The Cardiovascular Risk in Young Finns Study

Prediction of cerebrovascular and cardiovascular events in patients with subclinical carotid atherosclerosis: the role of C-reactive protein.

Dietary glycemic index, dietary glycemic load, blood lipids, and C-reactive protein

Comparison of Usefulness of C-reactive Protein Versus White Blood Cell Count to Predict Outcome After Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction

Biomarkers of Inflammation and Thrombosis as Predictors of Near-Term Mortality in Patients with Peripheral Arterial Disease: A Cohort Study

Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk